SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Drug Trials Suffer From Little Diversity
April 3, 2008
 · 
1 min read
Lone Star Bio
Gene Mutations Tied To Immune Comeback During Therapy For HIV-1, University of Texas Health Science Center
April 2, 2008
 · 
1 min read
Biotech Bay
Party Like It’s 1999
April 1, 2008
 · 
1 min read
Biotech Bay
Dinosaurs and Drug Companies
April 1, 2008
 · 
2 min read
Biotech Bay
Desperate But Not Crazy
April 1, 2008
 · 
2 min read
Biotech Bay
Keeping Your Hands Clean
March 31, 2008
 · 
3 min read
Biotech Bay
Biogenerics in ’08?
March 31, 2008
 · 
2 min read
Biotech Bay
Time to Buy Biotech?
March 31, 2008
 · 
3 min read
Lone Star Bio
Once-Daily Insulin Shot Proves Effective in Study
March 28, 2008
 · 
1 min read
Lone Star Bio
Texas Instruments’ Computer Chips Are Improving Medical Devices
March 27, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy
February 16, 2026
 · 
3 min read
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
 · 
4 min read
Press Releases
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
February 13, 2026
 · 
11 min read
Press Releases
Medicenna Announces Changes to Board Composition
February 13, 2026
 · 
6 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
February 12, 2026
 · 
1 min read
Press Releases
Tvardi Therapeutics to Participate in Upcoming Investor Conferences - February 12, 2026
February 12, 2026
 · 
1 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
February 11, 2026
 · 
4 min read
Press Releases
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
February 11, 2026
 · 
4 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
 · 
5 min read
Load More